Imunon, Inc. - Common Stock (IMNN)
1.4300
-0.1900 (-11.73%)
NASDAQ · Last Trade: Jun 14th, 11:41 AM EDT
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · June 12, 2025
Via Benzinga · June 11, 2025
Via Benzinga · June 10, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · June 10, 2025
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · June 10, 2025

Via Benzinga · June 4, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · May 30, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.
Via Chartmill · May 30, 2025

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · May 30, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · May 29, 2025

Via Benzinga · May 29, 2025

Via Benzinga · May 29, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
Via Chartmill · May 28, 2025

Via Benzinga · May 28, 2025

Unusual volume stocks in Wednesday's session
Via Chartmill · May 28, 2025

The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · May 28, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Via Chartmill · May 28, 2025

Via Benzinga · May 28, 2025

Via Benzinga · May 28, 2025

The data highlights promising results for IMNN-001, an IL-12 gene therapy for advanced ovarian cancer, boosting investor optimism ahead of its Phase 3 trial.
Via Stocktwits · May 27, 2025
Via Benzinga · May 27, 2025
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · May 27, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · May 27, 2025
Volume analysis on 2025-05-27: stocks with an unusual volume in today's session.
Via Chartmill · May 27, 2025